Norifumi Kawada
#156,466
Most Influential Person Now
Norifumi Kawada's AcademicInfluence.com Rankings
Norifumi Kawadamedical Degrees
Medical
#3067
World Rank
#3519
Historical Rank
Pharmacology
#361
World Rank
#412
Historical Rank

Download Badge
Medical
Norifumi Kawada's Degrees
- PhD Pharmacology University of Tokyo
- Masters Pharmacology University of Tokyo
- Bachelors Pharmacy University of Tokyo
Why Is Norifumi Kawada Influential?
(Suggest an Edit or Addition)Norifumi Kawada's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. (1999) (577)
- Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection (2014) (538)
- Effect of antioxidants, resveratrol, quercetin, and N‐acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells (1998) (411)
- The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. (1993) (387)
- Characterization of a Stellate Cell Activation-associated Protein (STAP) with Peroxidase Activity Found in Rat Hepatic Stellate Cells* (2001) (322)
- [Drug-induced cholestasis]. (1995) (291)
- Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population (2011) (288)
- Effects of sho‐saiko‐to, a japanese herbal medicine, on hepatic fibrosis in rats (1999) (239)
- MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis (2012) (224)
- Proteome analysis of rat hepatic stellate cells (2000) (204)
- A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease (2011) (185)
- In Vitro Migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation (1999) (161)
- Suppression of hepatic stellate cell activation by microRNA-29b. (2011) (155)
- Eicosanoid-mediated contractility of hepatic stellate cells. (1992) (152)
- Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. (2007) (141)
- Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts (2011) (137)
- Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats (2006) (136)
- Inflammation and fibrogenesis in steatohepatitis (2012) (135)
- Stimulation of Proliferation of Rat Hepatic Stellate Cells by Galectin-1 and Galectin-3 through Different Intracellular Signaling Pathways* (2003) (135)
- Cytoglobin/STAP, its unique localization in splanchnic fibroblast-like cells and function in organ fibrogenesis (2004) (133)
- Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. (2010) (127)
- Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: Impact on disease progression (2006) (125)
- Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells. (1999) (118)
- Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta. (2001) (117)
- Interferon alfa down‐regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice (2003) (116)
- BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2. (2006) (105)
- Structural basis of human cytoglobin for ligand binding. (2004) (104)
- Platelet count for predicting fibrosis in nonalcoholic fatty liver disease (2011) (102)
- Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF‐β in liver stellate cells (1997) (101)
- Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice (2003) (97)
- Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C (2011) (95)
- Endothelin‐1–induced vasoconstriction causes a significant increase in portal pressure of rat liver: Localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction (1998) (94)
- Role of the Gut–Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship (2019) (94)
- Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan (2014) (92)
- Characterization of the heme environmental structure of cytoglobin, a fourth globin in humans. (2003) (91)
- Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection. (2017) (89)
- Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis (2013) (89)
- Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients (2007) (88)
- Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study (2020) (87)
- Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. (2009) (86)
- ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1. (1999) (85)
- Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis. (2014) (85)
- Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma (2015) (84)
- Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice. (2005) (82)
- Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo. (1999) (82)
- Down‐regulation of cyclin E1 expression by microrna‐195 accounts for interferon‐β‐induced inhibition of hepatic stellate cell proliferation (2011) (81)
- Role of hepatitis B virus DNA integration in human hepatocarcinogenesis. (2014) (81)
- Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP‐470 in rats (2000) (79)
- Impaired liver regeneration in mice by lipopolysaccharide via TNF-α/kallikrein–mediated activation of latent TGF-β (2002) (79)
- Promotion of liver and lung tumorigenesis in DEN-treated cytoglobin-deficient mice. (2011) (78)
- The hepatic perisinusoidal stellate cell. (1997) (77)
- The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease (2020) (77)
- Induction of microRNA-214-5p in human and rodent liver fibrosis (2012) (76)
- Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice. (2005) (74)
- Regulation of endothelin‐1 action on the perfused rat liver (1993) (73)
- Assessment of Liver Fibrosis with Real-Time Tissue Elastography in Chronic Viral Hepatitis (2013) (73)
- Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study. (2000) (73)
- The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study (2016) (72)
- Comparison of Hepatocellular Carcinoma miRNA Expression Profiling as Evaluated by Next Generation Sequencing and Microarray (2014) (71)
- Inhibition of Transforming Growth Factor &bgr; Signaling by Halofuginone as a Modality for Pancreas Fibrosis Prevention (2009) (70)
- Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. (2003) (70)
- Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary Cholangitis (2019) (69)
- Cytoglobin regulates blood pressure and vascular tone through nitric oxide metabolism in the vascular wall (2017) (69)
- Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression. (1999) (68)
- The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis (2013) (67)
- Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers (2005) (67)
- Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium (2009) (67)
- Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats. (2004) (65)
- Expression of neural cell adhesion molecule (N-CAM) in perisinusoidal stellate cells of the human liver (1995) (65)
- Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells. (1997) (64)
- A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers (2015) (64)
- Structural characterization of the proximal and distal histidine environment of cytoglobin and neuroglobin. (2005) (63)
- In vivo and in vitro Interactions between Human Colon Carcinoma Cells and Hepatic Stellate Cells (2000) (59)
- Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis (2013) (59)
- Transient Elastography-Based Liver Profiles in a Hospital-Based Pediatric Population in Japan (2015) (59)
- Pathogenesis of adult-onset type II citrullinemia caused by deficiency of citrin, a mitochondrial solute carrier protein: tissue and subcellular localization of citrin. (2001) (58)
- HOMA‐IR: An independent predictor of advanced liver fibrosis in nondiabetic non‐alcoholic fatty liver disease (2019) (58)
- Add‐on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine‐refractory hepatitis B virus (2010) (56)
- Cytoglobin, a novel member of the globin family, protects kidney fibroblasts against oxidative stress under ischemic conditions. (2011) (56)
- Evolution of hepatic fibrosis research (2011) (56)
- Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy (2010) (56)
- Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine–choline-deficient diet (2010) (56)
- Recent Advances in Antiviral Therapy for Chronic Hepatitis C (2016) (55)
- MicroRNAs in hepatic pathophysiology (2017) (55)
- Interferon‐gamma–mediated tissue factor expression contributes to T‐cell‐mediated hepatitis through induction of hypercoagulation in mice (2013) (54)
- Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect (2007) (54)
- Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study. (2006) (52)
- MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice. (2016) (52)
- Cytoglobin is expressed in hepatic stellate cells, but not in myofibroblasts, in normal and fibrotic human liver (2014) (50)
- Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-β signaling (2007) (50)
- Serum Mac‐2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis (2013) (50)
- Expression of heat-shock protein 47 in mouse liver (1996) (48)
- Hepatitis B virus infection and alcohol consumption (2017) (48)
- Macrophage scavenger receptor down-regulates mycobacterial cord factor-induced proinflammatory cytokine production by alveolar and hepatic macrophages. (2006) (47)
- Effect of adrenomedullin on hepatic pericytes (stellate cells) of the rat (1994) (47)
- Inhibition of Pancreatic Stellate Cell Activation by Halofuginone Prevents Pancreatic Xenograft Tumor Development (2010) (47)
- A randomized pilot trial of oral branched‐chain amino acids in early cirrhosis: Validation using prognostic markers for pre–liver transplant status (2009) (46)
- Cytoglobin deficiency promotes liver cancer development from hepatosteatosis through activation of the oxidative stress pathway. (2015) (45)
- Expression of SPARC by activated hepatic stellate cells and its correlation with the stages of fibrogenesis in human chronic hepatitis (2002) (45)
- Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture. (1999) (44)
- Impaired liver regeneration in mice by lipopolysaccharide via TNF-alpha/kallikrein-mediated activation of latent TGF-beta. (2002) (44)
- Regulation of Cell Growth by Redox-mediated Extracellular Proteolysis of Platelet-derived Growth Factor Receptor β* (2001) (44)
- The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver Disease (2018) (44)
- A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits. (2010) (42)
- Kupffer cell-mediated recruitment of rat dendritic cells to the liver: roles of N-acetylgalactosamine-specific sugar receptors. (2001) (42)
- Applicability of BARD score to Japanese patients with NAFLD (2009) (41)
- Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis (2009) (41)
- Expression of cellular prion protein in activated hepatic stellate cells. (1998) (40)
- The impact of hepatitis C virus outside the liver: Evidence from Asia (2017) (40)
- Virological Escape in HCV Genotype-1-Infected Patients Receiving Daclatasvir plus Ribavirin and Peginterferon Alfa-2A or Alfa-2B (2014) (39)
- Characterization of human stellate cell activation-associated protein and its expression in human liver. (2002) (38)
- Regulation by cAMP of STAT1 activation in hepatic stellate cells. (1997) (38)
- Typing of hepatic nonparenchymal cells using fibulin-2 and cytoglobin/STAP as liver fibrogenesis-related markers (2004) (38)
- Absence of cytoglobin promotes multiple organ abnormalities in aged mice (2016) (37)
- Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling. (2007) (37)
- Expression of Connective Tissue Growth Factor in the Human Liver with Idiopathic Portal Hypertension (2007) (36)
- Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis. (2006) (35)
- Use of Mac‐2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis (2017) (35)
- Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma (2020) (34)
- Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease (2005) (34)
- The Alcohol Use Disorders Identification Test for Consumption (AUDIT-C) is more useful than pre-existing laboratory tests for predicting hazardous drinking: a cross-sectional study (2016) (33)
- A Clinical Quantitative Evaluation of Hepatobiliary Transport of [11C]Dehydropravastatin in Humans Using Positron Emission Tomography (2018) (33)
- Identification of vitamin A-free cells in a stellate cell-enriched fraction of normal rat liver as myofibroblasts (2007) (33)
- Nutritional status in relation to lifestyle in patients with compensated viral cirrhosis. (2012) (33)
- Daclatasvir Combined with Peginterferon Alfa-2A and Ribavirin in Japanese Patients Infected with Hepatitis C Genotype 1 (2014) (32)
- Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus (2009) (32)
- High-resolution structure of human cytoglobin: identification of extra N- and C-termini and a new dimerization mode. (2006) (32)
- Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct‐acting antiviral therapy (2018) (31)
- Attenuation of acute and chronic liver injury in rats by iron-deficient diet. (2008) (31)
- Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C. (2007) (31)
- Fibrogenesis in alcoholic liver disease. (2014) (31)
- Hepatic stellate cell nomenclature. (1996) (30)
- Apoptosis of T cells in the hepatic fibrotic tissue of the rat: a possible inducing role of hepatic myofibroblast-like cells (2003) (30)
- Smooth muscle alpha-actin expression in rat hepatic stellate cell is regulated by nitric oxide and cGMP production. (1996) (30)
- Entecavir to treat hepatitis B-associated cryoglobulinemic vasculitis. (2008) (29)
- Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug‐resistant variants during lamivudine therapy: Analyses of the polymerase gene and full‐length sequences (2007) (28)
- N-Acetylglucosaminyltransferase V regulates TGF-β response in hepatic stellate cells and the progression of steatohepatitis. (2012) (28)
- Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling (2017) (28)
- Ledipasvir‐sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection (2018) (28)
- Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway (2012) (27)
- HLA class II associated with outcomes of hepatitis B and C infections. (2013) (27)
- Rho kinases regulate endothelial invasion and migration during valvuloseptal endocardial cushion tissue formation (2006) (27)
- Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma (2017) (27)
- Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B. (2014) (26)
- Carbenoxolone inhibits DNA synthesis and collagen gene expression in rat hepatic stellate cells in culture. (2003) (26)
- Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study (2020) (25)
- Interferon gamma modulates production of interleukin 1 and tumor necrosis factor by murine Kupffer cells. (2008) (25)
- Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis (2006) (24)
- Apoptosis: A new mechanism of endothelial and Kupffer cell killing (1995) (24)
- Induction of tropomyosin during hepatic stellate cell activation and the progression of liver fibrosis (2009) (24)
- Regulation of cultured rat hepatocyte proliferation by stellate cells. (2002) (24)
- Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C (2018) (24)
- Nucleotide receptors in hepatic stellate cells of the rat (1994) (24)
- Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization (2009) (23)
- Benefits of artificially induced pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma located on the liver surface and in the hepatic dome. (2012) (22)
- Prospective long‐term study of hepatitis B virus reactivation in patients with hematologic malignancy (2014) (22)
- Outcomes of laparoscopic hepatic resection versus percutaneous radiofrequency ablation for hepatocellular carcinoma located at the liver surface: A case–control study with propensity score matching (2016) (22)
- High Prevalence of Gastroesophageal Reflux Symptoms in Patients with Non-Alcoholic Fatty Liver Disease Associated with Serum Levels of Triglyceride and Cholesterol but Not Simple Visceral Obesity (2012) (22)
- Possible Involvement of Nitric Oxide in Enhanced Liver Injury and Fibrogenesis during Cholestasis in Cytoglobin-deficient Mice (2017) (22)
- Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China (2020) (22)
- Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential (2013) (22)
- Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B (2013) (22)
- Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro‐carcinogenesis in chronic hepatitis C (2013) (21)
- Electrophysiological characterization of cultured hepatic stellate cells in rats. (1997) (21)
- Intention‐to‐treat assessment of glecaprevir + pibrentasvir combination therapy for patients with chronic hepatitis C in the real world (2019) (21)
- Calcium-dependent prostaglandin biosynthesis by lipopolysaccharide-stimulated rat Kupffer cells. (1992) (21)
- Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cells (2009) (21)
- Effects of arachidonic acid metabolites and interleukin‐1 on platelet activating factor production by hepatic sinusoidal endothelial cells from mice (1991) (20)
- Clinicopathological characterization of prion: a novel marker of activated human hepatic stellate cells. (2000) (20)
- Morphological study of endothelin-1-induced contraction of cultured hepatic stellate cells on hydrated collagen gels (1996) (19)
- Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts (2015) (19)
- The Hemoglobin Homolog Cytoglobin in Smooth Muscle Inhibits Apoptosis and Regulates Vascular Remodeling (2017) (19)
- Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMP (1996) (19)
- Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis (2017) (19)
- Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas (2017) (19)
- The hepatic stellate cell in the post-genomic era. (2002) (18)
- Epiregulin stimulates proliferation of rabbit gastric cells in primary culture through autophosphorylation of the epidermal growth factor receptor. (1997) (18)
- The anti-oxidative role of cytoglobin in podocytes: implications for a role in chronic kidney disease. (2020) (18)
- Hepatic expression of c‐Myb in chronic human liver disease (1997) (18)
- Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-Based Cohort Study. (2022) (18)
- Expression of cytochrome P450 isoforms in rat hepatic stellate cells. (1997) (17)
- Inhibition of the activation of hepatic stellate cells by arundic acid via the induction of cytoglobin. (2012) (17)
- Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection (2009) (17)
- Sulfur-containing amino acids attenuate the development of liver fibrosis in rats through down-regulation of stellate cell activation. (2004) (17)
- Circulating Exosomal miRNA Profiles Predict the Occurrence and Recurrence of Hepatocellular Carcinoma in Patients with Direct-Acting Antiviral-Induced Sustained Viral Response (2019) (17)
- Effect of Mosapride Citrate on Gastric Emptying in Interferon-Induced Gastroparesis (2012) (16)
- Immunohistochemical characterization of cancer-associated fibroblasts at the primary sites and in the metastatic lymph nodes of human intrahepatic cholangiocarcinoma. (2019) (16)
- Close correlation of liver stiffness with collagen deposition and presence of myofibroblasts in non‐alcoholic fatty liver disease (2011) (16)
- Changes in leukotrienes and prostaglandins in the liver tissue of rats in the experimental massive hepatic cell necrosis model. (1990) (16)
- Retinoic acid-stimulated liver stellate cells suppress the production of albumin from parenchymal cells via TGF-beta. (1996) (16)
- Selective overexpression of cytoglobin in stellate cells attenuates thioacetamide-induced liver fibrosis in mice (2018) (16)
- Role of oxidative stress and Kupffer cells in hepatic fibrosis (2007) (16)
- Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status (2018) (16)
- Involvement of hepatic stellate cell cytoglobin in acute hepatocyte damage through the regulation of CYP2E1-mediated xenobiotic metabolism (2015) (15)
- Obesity and hiatal hernia may be non-allergic risk factors for esophageal eosinophilia in Japanese adults (2019) (15)
- Thioredoxin prevents thioacetamide-induced acute hepatitis (2004) (15)
- Noninvasive Diagnosis of Liver Fibrosis: Utility of Data Mining of Both Ultrasound Elastography and Serological Findings to Construct a Decision Tree (2014) (15)
- Prediction for Improvement of Liver Function after Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices to Manage Portosystemic Shunt Syndrome. (2016) (15)
- Thiopurine S‐methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases (2007) (15)
- A case of sclerosing cholangitis with autoimmune pancreatitis evaluated by FDG-PET (2007) (15)
- Effect of S-adenosyl-L-methionine on the activation, proliferation and contraction of hepatic stellate cells. (2005) (15)
- MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy (2016) (15)
- Discovery of cytoglobin and its roles in physiology and pathology of hepatic stellate cells (2016) (15)
- Relationship between inosine triphosphate genotype and outcome of extended therapy in hepatitis C virus patients with a late viral response to pegylated‐interferon and ribavirin (2014) (15)
- Mechanism that regulates nitric oxide production by lipopolysaccharide-stimulated rat Kupffer cells. (1996) (15)
- Pepstatin A attenuates the inhibitory effect of N-acetyl-L-cysteine on proliferation of hepatic myofibroblasts (stellate cells). (2002) (14)
- Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection? (2006) (14)
- Positioning of 18F‐fluorodeoxyglucose‐positron emission tomography imaging in the management algorithm of hepatocellular carcinoma (2014) (14)
- Possible induction of fatty acid cyclo-oxygenase in lipopolysaccharide-stimulated rat Kupffer cells. (1992) (14)
- Rho kinase inhibitor Y27632 affects initial heart myofibrillogenesis in cultured chick blastoderm (2007) (14)
- Effect of gomisin A in the prevention of acute hepatic failure induction. (1991) (14)
- Anti-fibrotic treatments for chronic liver diseases: The present and the future (2020) (14)
- Putting “sticky notes” on the electronic medical record to promote intra-hospital referral of hepatitis B and C virus-positive patients to hepatology specialists: an exploratory study (2016) (13)
- Focal nodular hyperplasia-like lesion with venous washout in alcoholic liver cirrhosis. (2008) (13)
- Clinical significance of pretreatment serum interferon‐gamma‐inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir‐based triple therapy (2014) (13)
- Emerging antiviral drugs for hepatitis C virus. (2009) (13)
- A complete response induced by 21-day sorafenib therapy in a patient with advanced hepatocellular carcinoma. (2013) (13)
- Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication (2018) (13)
- Maintenance of hepatocyte functions in coculture with hepatic stellate cells (2004) (13)
- Immunohistochemical detection of Fas and apoptosis in type-1 autoimmune hepatitis. (2003) (13)
- Cytoglobin expression of rectal subepithelial myofibroblasts: significant alterations of cytoglobin+ stromal cells in long-standing ulcerative colitis. (2011) (12)
- Action of endothelins on hepatic stellate cells (1995) (12)
- Expression of progenitor cell markers in livers with fulminant massive necrosis. (2003) (12)
- Changes in sequences of core region, interferon sensitivity‐determining region and interferon and ribavirin resistance‐determining region of hepatitis C virus genotype 1 during interferon‐alpha and ribavirin therapy, and efficacy of retreatment (2012) (12)
- The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor‐naïve patients with chronic HCV genotype 1b infection in a real‐world cohort (2018) (12)
- Effect of Caffeine-Containing Beverage Consumption on Serum Alanine Aminotransferase Levels in Patients with Chronic Hepatitis C Virus Infection: A Hospital-Based Cohort Study (2013) (12)
- Interferon-β plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial (2005) (12)
- Non-invasive diagnosis of liver fibrosis (2011) (12)
- Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon‐α2b and ribavirin therapy in patients with genotype 1 and high viral loads (2005) (12)
- Increased 5‐lipoxygenase activity in massive hepatic cell necrosis in the rat correlates with neutrophil infiltration (1992) (11)
- Expression of Fas and Bcl-2 proteins and induction of apoptosis in human hepatocellular carcinoma cell lines (1999) (11)
- 1193 A DESCRIPTION OF VIROLOGIC ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH DACLATASVIR (BMS-790052) IN COMBINATION WITH RIBAVIRIN AND PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B (2012) (11)
- Role of Oxidative and Nitrosative Stress in Hepatic Fibrosis (2017) (11)
- Gasdermin D–mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma (2022) (11)
- Characterization of vitamin A-storing cells in mouse fibrous kidneys using Cygb/STAP as a marker of activated stellate cells. (2007) (11)
- Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas (2020) (11)
- Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis (2022) (11)
- Molecular mechanism of stellate cell activation and therapeutic strategy for liver fibrosis (2004) (11)
- Involvement of Galectin-1 and Galectin-3 in Proliferation and Migration of Rat Hepatic Stellate Cells in Culture (2004) (11)
- Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis (2021) (11)
- Role of nitric oxide in extracellular nucleotide-induced contractile status of assorted vessels including parts of the portal vasculature. (1998) (10)
- Hexa Histidine–Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species (2021) (10)
- [Drug-induced liver injury caused by an herbal medicine, bofu-tsu-sho-san]. (2008) (10)
- Regulation of stellate cell proliferation by lipopolysaccharide: Role of endogenous nitric oxide (1998) (10)
- Regulation of stellate cell proliferation by lipopolysaccharide: role of endogenous nitric oxide. (1998) (9)
- Association between HLA‐DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment (2018) (9)
- Cancer serum proteomics in gastroenterology. (2006) (9)
- Response‐guided therapy for patients with chronic hepatitis who have high viral loads of hepatitis C virus genotype 2 (2012) (9)
- Prevalence and risk factors of functional constipation in the Rome IV criteria during a medical check‐up in Japan (2021) (9)
- Association between Functional Dyspepsia and Gastric Depressive Erosions in Japanese Subjects (2018) (9)
- Development of novel hepatitis B virus capsid inhibitor using in silico screening. (2015) (9)
- Interstitial fluid flow-induced growth potential and hyaluronan synthesis of fibroblasts in a fibroblast-populated stretched collagen gel culture. (2017) (9)
- Discovering novel direct acting antiviral agents for HBV using in silico screening. (2015) (9)
- TGF-β-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis. (2020) (9)
- Lamivudine and IFN-beta sequential therapy in HBe antigen-positive patients with chronic hepatitis B virus genotype C infection. (2007) (9)
- Synthesis of eicosanoids by Propionibacterium acnes-elicited liver adherent cells and their effect on production of interleukin 1 and tumor necrosis factor. (1990) (9)
- Eosinophilic esophagitis and asymptomatic esophageal eosinophilia display similar immunohistological profiles (2020) (8)
- Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization (2020) (8)
- Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir. (2021) (8)
- Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy (2017) (8)
- Establishment and characteristics of human hepatocellular carcinoma cells with metastasis to lymph nodes. (1999) (8)
- A case of primary small cell carcinoma of the liver that was treated with chemotherapy (2008) (8)
- Randomized trial of combined triple therapy comprising two types of peginterferon with simeprevir in patients with hepatitis C virus genotype 1b (2016) (8)
- Clinical role of FDG-PET for HCC: relationship of glucose metabolic indicator to Japan Integrated Staging (JIS) score. (2008) (8)
- Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination. (2017) (8)
- Usefulness of a New Immunoradiometric Assay of HCV Core Antigen to Predict Virological Response during PEG-IFN/RBV Combination Therapy for Chronic Hepatitis with High Viral Load of Serum HCV RNA Genotype 1b (2008) (8)
- Arachidonate metabolism in D-galactosamine or carbon tetrachloride-induced acute and chronic liver injuries in rats (1992) (7)
- Regression of portal hypertension: underlying mechanisms and therapeutic strategies (2021) (7)
- Effect of glycyrrhizin and glycyrrhetinic acid on arachidonic acid metabolism in peritoneal exudate cells of rat. (1989) (7)
- Arachidonic acid metabolites in carbon tetrachloride-induced liver injury (1990) (7)
- A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis (2020) (7)
- Involvement of ERK1/2 activation in the gene expression of senescence-associated secretory factors in human hepatic stellate cells (2018) (7)
- Heterogeneous liver uptake of Tc-99m-GSA as quantified through SPECT/CT helps to evaluate the degree of liver fibrosis (2018) (7)
- Interferon-β Mediates Signaling Pathways Uniquely Regulated in Hepatic Stellate Cells and Attenuates the Progression of Hepatic Fibrosis in a Dietary Mouse Model. (2015) (7)
- Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma (2019) (7)
- Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg‐negative chronic hepatitis B: a randomized trial (2008) (7)
- Switching to tenofovir disoproxil fumarate vs continuing treatment in patients with chronic hepatitis B who maintain long‐term virological response to entecavir therapy: A randomized trial (2019) (7)
- Significant role of apoptosis in type-1 autoimmune hepatitis. (1999) (7)
- Sildenafil-Induced Severe Cholestatic Hepatotoxicity (2009) (7)
- Primary localized cutaneous amyloidosis associated with autoimmune cholangitis (2000) (6)
- Cytoglobin May Be Involved in the Healing Process of Gastric Mucosal Injuries in the Late Phase Without Angiogenesis (2013) (6)
- Development of a novel anti-hepatitis B virus agent via Sp1 (2020) (6)
- Enhancement of prostaglandin E2 production by liver macrophages (Kupffer cells) after stimulation with biological response modifiers. (1992) (6)
- Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials (2020) (6)
- High prevalence of hepatitis C virus infection in Airin district, Osaka, Japan: A hospital‐based study of 1162 patients (2011) (6)
- Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis (2020) (6)
- Pancreatic Cancer Cell Fraction Estimation in a DNA Sample (2018) (6)
- Immunohistochemical and ultrastructural analyses of in situ activation of hepatic stellate cells around Propionibacterium acnes-induced granulomas in the rat liver. (1997) (6)
- Surgical Outcomes in Hepatitis C Virus-Related Hepatocellular Carcinoma: Special Reference to Sustained Virological Responses to Interferon Therapy (2017) (5)
- Suppression of Rat Stellate Cell Activation and Liver Fibrosis by a Japanese Herbal Medicine, Inchinko-to (TJ135) (2004) (5)
- The Moral of Hepatic Fibrosis: Don’t Always Believe Noninvasive Fibrosis Measurements (2020) (5)
- Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed (2017) (5)
- Interactions of Stellate Cells with Other Non-Parenchymal Cells (2015) (5)
- Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis (2020) (5)
- Tolerance and acceptance of hepatic venous pressure gradient measurement in cirrhosis (CHESS1904): An international multicenter study (2022) (5)
- Extracellular nucleotides modulate the portal circulation with generation of nitric oxide (1998) (5)
- Pathophysiological role of cytoglobin, the fourth globin in mammals, in liver diseases. (2016) (5)
- Sequential therapy involving an early switch from entecavir to pegylated interferon‐α in Japanese patients with chronic hepatitis B (2018) (5)
- Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals (2018) (5)
- Effects on anemia of drug adjustment in patients with chronic hepatitis C during telaprevir-combined therapy. (2015) (5)
- Analysis of proteins dominantly expressed in hepatic stellate cells of activated phenotype. (2005) (5)
- Surgical outcomes for hepatocellular carcinoma detected after hepatitis C virus eradiation by direct‐acting antivirals (2020) (5)
- Synthesis of interleukin 1 by liver adherent cells of Kupffer cells and its regulation with prostaglandin. (1989) (5)
- Injection Site with Generalized Rash Caused by Pegylated Interferon Alpha 2a Injection (2005) (5)
- Lifestyle changes during the coronavirus disease 2019 pandemic impact metabolic dysfunction–associated fatty liver disease (2022) (5)
- Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma (2018) (5)
- The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases (2021) (5)
- Development of non-invasive method for assessment of hepatic steatosis. (2016) (5)
- Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species (2022) (5)
- Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients. (2020) (4)
- Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study (2021) (4)
- Utility of Kyoto Classification of Gastritis in subjects with a high-negative titer of anti-Helicobacter pylori antibody during a medical check-up (2020) (4)
- Does a late evening meal reduce the risk of hepatocellular carcinoma among patients with chronic hepatitis C? (2008) (4)
- Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-β in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection. (2015) (4)
- Promotion of intra-hospital referral of hepatitis B and C virus carriers to hepatology specialists by electronic medical record-based alert system: a case study at a university hospital (2016) (4)
- Favorable factors for re‐treatment with pegylated interferon α2a plus ribavirin in patients with high viral loads of genotype 1 hepatitis C virus (2011) (4)
- Exosomal hsa-miR-933 in Gastric Juice as a Potential Biomarker for Functional Dyspepsia (2020) (4)
- Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: A multicenter cohort study (2020) (4)
- Postoperative direct‐acting antiviral treatment after liver resection in patients with hepatitis C virus‐related hepatocellular carcinoma (2021) (4)
- [Current situation and future prospect of cytoglobin research]. (2013) (4)
- Treatment guidelines for HCV genotype 1: mono for low, triple for high, and dual for ‘middle’? (2013) (3)
- [Rabbit model for the study of human NASH]. (2006) (3)
- The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis (2013) (3)
- Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C (2020) (3)
- [Detection of leukotrienes in rat liver tissue]. (1988) (3)
- [Release of peptide leukotrienes from rat Kupffer cells]. (1988) (3)
- Interferon γ stimulates prostaglandin E2 production by mouse Kupffer cells (1990) (3)
- Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein (2020) (3)
- Serotonin and tryptamine metabolism in the acute hepatic failure model: changes in tryptophan and its metabolites in the liver, brain and kidney. (1989) (3)
- Interferon‐α/β for treatment of chronic hepatitis C infection in the era of direct‐acting antiviral agents (2014) (3)
- Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma. (2020) (3)
- Combination therapy of natural human interferon‐beta and ribavirin for chronic hepatitis C patients with injection drug use (2013) (3)
- Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy (2021) (3)
- Characterization of arachidonate 12-lipoxygenase found in the liver of mongrel dog and its immunohistochemical localization in neutrophils. (1995) (3)
- [Effects of magnesium lithospermate B on cyclooxygenase activity in rat liver, adherent cells and enzyme's product]. (1994) (3)
- New player in tumor‐stromal interaction: Granulin as a novel therapeutic target for pancreatic ductal adenocarcinoma liver metastasis (2017) (3)
- The protective effects of Sho-saiko-to in an experimental, immunologically-induced allergic hepatic cell injury (1990) (3)
- Platelet‐associated IgG for the diagnosis of immune thrombocytopaenic purpura during peginterferon α and ribavirin treatment for chronic hepatitis C (2008) (3)
- Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis C (2020) (3)
- Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment (2021) (3)
- Outcome of nucleos(t)ide analog intervention in patients with preventive or on‐demand therapy for hepatitis B virus reactivation (2020) (3)
- A pregnant woman with acute hepatitis B in whom vertical transmission was prevented by tenofovir disoproxil fumarate (2013) (2)
- Genome-Wide Association Study Identi fi es TLL 1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection (2017) (2)
- Destructive thyroiditis presenting as thyrotoxicosis followed by hypothyroidism during lenvatinib therapy for hepatocellular carcinoma (2020) (2)
- The Administration of Tenofovir Disoproxil Fumarate for Pregnant Japanese Women with Chronic Hepatitis B (2020) (2)
- Could Trastuzumab Suppress Hepatitis C Virus in a Patient With Chronic Hepatitis and Breast Cancer? (2011) (2)
- Successful Transcatheter Arterial Embolization for Hemothorax from a Spontaneous Rupture of Hepatocellular Carcinoma Metastasis to the Chest Wall in an Elderly Patient (2021) (2)
- Cancer cells produce liver metastasis via gap formation in sinusoidal endothelial cells through proinflammatory paracrine mechanisms (2022) (2)
- Direct‐acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment (2021) (2)
- Antifibrotic role of macrophage migration inhibitory factor: Discovery of an unexpected function (2012) (2)
- The effect of lipo-prostaglandin E1 on the production of interleukin 1 and platelet-activating factor by hepatic sinusoidal endothelial cells in mice. (1991) (2)
- Risk factors for hepatocellular carcinoma in treated chronic hepatitis C patients–Relationship to smoking and alcohol (2020) (2)
- High resolution structure of cytoglobin reveals the extra helix in N-terminus (2005) (2)
- The Alcohol Use Disorders. Identification Test (AUDIT) score is useful for predicting alcohol consumption. (2016) (2)
- [Tumor lysis syndrome after transarterial embolization for hepatocellular carcinoma]. (2013) (2)
- A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C (2021) (2)
- Interferon gamma stimulates prostaglandin E2 production by mouse Kupffer cells. (1990) (2)
- The Albumin-bilirubin Score Detects Changes in the Liver Function during Treatment for Budd-Chiari Syndrome: A Retrospective Observational Study (2021) (2)
- P3-17 Expression of STAP (stellate cell activation-associated protein) in the visceral fibroblasts of rats (2002) (2)
- Sofosbuvir/Velpatasvir Plus Ribavirin Combination Therapy for Patients with Hepatitis C Virus Genotype 1a, 2a, or 3b after Glecaprevir/Pibrentasvir Therapy Failed (2021) (2)
- Effects of arachidonic acid metabolites and platelet-activating factor(PAF) on interleukin-1 synthesis from mouse hepatic sinusoidal endothelium. (1990) (2)
- Hepatitis C virus recurrence in two patients who achieved sustained viral response with interferon-free direct-acting antiviral therapy: reinfection or relapse? (2019) (2)
- Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for Hepatolithiasis (2020) (2)
- Retinoids and Liver Fibrosis (1999) (2)
- Control of HCV Replication With iMIRs, a Novel Anti-RNAi Agent (2015) (2)
- Cytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species (2022) (2)
- TRANSFUSION-TRANSMITTED HBV INFECTION DETECTED BY LOOKBACK STUDY FOR BLOOD DONOR-A CASE REPORT (2008) (2)
- Plasma xanthine oxidoreductase activity change over 12 months independently associated with change in serum uric acid level: MedCity21 health examination registry (2020) (2)
- Validation of a two‐step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis (2021) (1)
- 410 USEFULNESS OF REAL-TIME TISSUE ELASTOGRAPHY FOR NONINVASIVE ASSESSMENT OF LIVER STIFFNESS IN PATIENTS WITH CHRONIC HEPATITIS C: VERSUS TRANSIENT ELASTOGRAPHY (FIBROSCAN) (2010) (1)
- Prognostic Nutrition Index as an Indicator of Therapeutic Response to Lenvatinib Therapy in Hepatocellular Carcinoma (2022) (1)
- High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug use (2020) (1)
- Short Communication Expression of Cellular Prion Protein in Activated Hepatic Stellate Cells (1998) (1)
- 931 EXPRESSION OF PERILIPIN AND ADIPOPHILIN IN HUMAN NONALCOHOLIC FATTY LIVER DISEASE AND THEIR RELATION TO OXIDATIVE DAMAGE (2008) (1)
- [Liver fibrosis--the forefront of the study on stellate cells]. (2001) (1)
- Hepatitis B-associated cryoglobulinemia and antiphospholipid antibodies (2010) (1)
- Handling of Activation Status of Human Hepatic Stellate Cells by Low-Molecular-Weight FGF2 via the Induction of Cytoglobin (2016) (1)
- Cytoglobin-expressing cells in the splenic cords contribute to splenic fibrosis in cirrhotic patients. (2020) (1)
- Anti‐hepatitis B virus therapy: To stop, or not to stop: Has the question been solved? (2012) (1)
- A case of autoimmune hepatitis showing resistance to a steroid and immunosuppressants (2009) (1)
- Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma (2020) (1)
- Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction? (2017) (1)
- A multicenter, retrospective, cohort study shows platelet counts predict HCC development in patients with NAFLD. (2023) (1)
- The Current Status of Non-Invasive Assessment of Liver Fibrosis: Real Time Tissue Elastography (2011) (1)
- A case series of five patients with hepatic sarcoidosis diagnosed by liver biopsy (2019) (1)
- Nitric Oxide Derived from Cytoglobin-Deficient Hepatic Stellate Cells Causes Suppression of Cytochrome c Oxidase Activity in Hepatocytes (2022) (1)
- [Serotonin and tryptamine metabolism in the acute hepatic failure model--changes in tryptophan and its metabolites in the liver, brain, kidney and serum]. (1990) (1)
- A case of hepatitis C virus-associated mixed cryoglobulinemic vasculitis treated with daclatasvir and asunaprevir (2016) (1)
- LPS-INDUCED APOPTOSIS IN KUPFFER CELLS (1995) (1)
- Network of cytokine and arachidonic acid cascade in acute hepatic failure (1993) (1)
- Activated Kupffer cells induce apoptosis in sinusoidal endothelial cells by juxtacrine mechanism (1994) (1)
- Response-Guided Peginterferon α-2a Monotherapy for Hemodialysis Patients with Chronic Hepatitis C (2014) (1)
- [The protective effects of glucagon and insulin in an experimental massive hepatic cell necrosis model]. (1990) (1)
- Mature Peritoneal Macrophages Take an Avascular Route Into the Injured Liver and Promote Tissue Repair (2016) (1)
- Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma (2023) (1)
- Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry (2022) (1)
- Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma. (2021) (1)
- Capacity of extracellular globins to reduce liver fibrosis via scavenging reactive oxygen species and promoting MMP-1 secretion (2022) (1)
- Half-Moon-shaped Aortic Arch Thrombosis Induced by Lenvatinib. (2021) (1)
- 292 A RANDOMIZED PILOT TRIAL OF ORAL BRANCHED-CHAIN AMINO ACIDS IN EARLY LIVER CIRRHOSIS (2008) (1)
- Regulation of stellate cell growth by redox-mediated extracellular proteolysis of platelet-derived growth factor receptor-B (2002) (1)
- Pathophysiology of acute obstructive cholangitis (1996) (1)
- Soluble Immune Checkpoint Protein CD27 Is a Novel Prognostic Biomarker of Hepatocellular Carcinoma Development in Hepatitis C Virus–Sustained Virological Response Patients (2022) (1)
- A case of drug-induced pneumonitis caused by transcatheter arterial infusion with miriplatin for hepatocellular carcinoma (2012) (1)
- Review The hepatic stellate cell in the post-genomic era (2002) (1)
- Effect of cepharanthine on metabolism of arachidonic acid from rat peritoneal exudate cells. (1988) (1)
- THU-183-Prospective multicenter study of glecaprevir plus pibrentasvir combination therapy for patients with chronic hepatitis C (2019) (1)
- Fatty change in human hepatocellular carcinoma cell lines derived from patients with antibodies to hepatitis C virus. (2002) (1)
- A case of hepatocellular carcinoma successfully treated by percutaneous radiofrequency ablation using the laparoscopic artificial ascites technique (2007) (0)
- Effect of adrenomedullin, a novel vasoactive peptide, on hepatic pericytes (stellate cells) of the rat (1995) (0)
- The safety and efficacy of hepatic arterial infusion chemotherapy with cisplatin. (2018) (0)
- Identification of gut bacterial candidates involved in hepatic encephalopathy by the analysis of feces DNA from patients administered rifaximin (2020) (0)
- Immunohistochemical study on collagen producing cells in pancreas (2016) (0)
- Repeat lung cancer screenings reveal less CXR abnormalities with different variations than first-time screening (2021) (0)
- [Latest anti-fibrotic therapies for chronic liver diseases]. (2020) (0)
- Soluble immune checkpoint protein CD27 is a novel prognostic biomarker of HCC development in HCV-SVR patients. (2022) (0)
- [Drug-induced hepatitis]. (1995) (0)
- P3-252Current Status and Perspective of Call Request in Lung Cancer Screening (2017) (0)
- [Sequential therapy with a nucleos(t)ide analogue and interferon in patients with chronic hepatitis B: efficacy and limitations]. (2011) (0)
- Effects of irsoglandine maleate in an experimentally-induced acute hepatic failure model using mice (1991) (0)
- Involvement of ERK1/2 activation in the gene expression of senescence-associated secretory factors in human hepatic stellate cells (2018) (0)
- P1050 LONG-TERM OUTCOME OF SEQUENTIAL THERAPY WITH LAMIVUDINE FOLLOWED BY INTERFERON IN NUCLEOSIDE-NAIVE, HEPATITIS B E ANTIGEN-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B VIRUS GENOTYPE C INFECTION (2014) (0)
- Identification of FGF2 as a cytoglobin regulatory factor leading to the deactivation of human hepatic stellate cells (2015) (0)
- II. Molecular Mechanism of Liver Fibrosis and the Markers in Blood (2022) (0)
- Function of nitric oxide in and around hepatic sinusoids (1994) (0)
- Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment (2022) (0)
- Amino acids, L-Cysteine and L-Methionine, Attenuate Activation of Rat Stellate Cells in Primary Culture (2004) (0)
- 315 PDGF receptor as a molecular target of antioxidants in stellate cell (2004) (0)
- Characterization of cancer associated fibroblasts in primary site and metaststic lymph nodes of intrahepatic cholangiocarcinoma by immunohistochmistry (2017) (0)
- Antioxidant Approach to the Therapy of Chronic Liver Diseases (2015) (0)
- Rat stellate cells regulate proliferation of rat hepatocytes in culture (2002) (0)
- Hydrophobic Residues Regulate Distal Histidine Coordinations in Human Cgb and Ngb (2010) (0)
- SPECIFIC SUPPRESSION OF TNF-?? PRODUCTION FROM ACTIVATED KUPFFER CELLS BY ANTISENSE DNA OLIGOMERS (1995) (0)
- Acute renal failure - basic research (2009) (0)
- Pancreatic cancer biomarkers among exosome-fractionated circulating miRNAs. (2016) (0)
- Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma (2022) (0)
- PDGF signaling in cell cycle progression of cultured rat hepatic stellate cells. (2000) (0)
- Changes in prostaglandins and leukotrienes in the liver tissue of guinea pigs in the experimental massive hepatic cell necrosis model. (1989) (0)
- GASTROINTESTINAL , HEPATOBILIARY , AND PANCREATIC PATHOLOGY Cytoglobin De fi ciency Promotes Liver Cancer Development from Hepatosteatosis through Activation of the Oxidative Stress Pathway (0)
- The role of nitric oxide of responses to nucleotides in rat hepatic vessels (1994) (0)
- [329] DAMAGED ERYTHROCYTES MAY BE ASSOCIATED WITH OXIDATIVE STRESS AND FIBROGENSIS IN A RABBIT MODEL OF STEATOHEPATITIS (2007) (0)
- Dynamics of Kupffer cells and stellate cells (1994) (0)
- Interferon α (2017) (0)
- Long-term outcome of pediatric non-cirrhotic portal fibrosis from the viewpoint of endoscopic profile (2020) (0)
- Detection of cyclooxygenase and 5-lipoxygenase activity in rat hepatocytes. (1990) (0)
- Title Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma (2018) (0)
- Risk factors for liver‐related and non‐liver‐related mortality following a sustained virological response after direct‐acting antiviral treatment for hepatitis C virus infection in a real‐world cohort (2022) (0)
- 1P162 Exogenous Ligand Binding Mechanism of Cytoglobin(5. Heme protein,Poster Session,Abstract,Meeting Program of EABS & BSJ 2006) (2006) (0)
- Antifibrotic Therapy for Liver Cirrhosis (2019) (0)
- Tryptophan metabolism in the liver, brain and kidney of mice with acute hepatic failure. (1988) (0)
- 501 18-BETA-GLYCYRRHETIC ACID, METABOLITE OF GLYCYRRHIZIN, INDUCES APOPTOSIS AND SUPPRESS THE EXPRESSION OF COLLAGEN TYPE I GENE IN HEPATIC STELLATE CELLS (2008) (0)
- The impact of liver function improvement after direct-acting antiviral therapy on the outcome in hepatitis C virus patients with decompensated cirrhosis (2022) (0)
- 431 PRE-EMPTIVE OR PROPHYLACTIC THERAPY FOR REACTIVATION OF HEPATITIS B VIRUS IN PATIENTS WHO RECEIVED IMMUNOSUPPRESSIVE OR CYTOTOXIC THERAPY: EVALUATION OF BOTH HBsAg-POSITIVE AND HBsAg-NEGATIVE COHORTS (2013) (0)
- Effect of Extract of Cultured Lentinus edodes mycelia (LEM) on Platelet Activating Factor Synthesis from Mouse Hepatic Sinusoidal Endothelial Cells (1992) (0)
- The hepatic sinusoid 'classic and contemporary’: a report on the 17th international symposium on cells of the hepatic sinusoid (ISCHS) (2014) (0)
- ISOLATION OF A NOVEL PROTEIN, STAP, FROM ACTIVATED STELLATE CELL BY PROTEOMICS (2001) (0)
- Crystal structure of human cytoglobin at 1.68 angstroms resolution (2006) (0)
- F8-6 Retinoic acid induces biphasic release and activation of latent transforming growth factor-β in rat stellate cell cultures (1995) (0)
- Annual lung cancer screening by chest x-ray results in higher profits for the exclusion of lung cancer. (2019) (0)
- Blood levels of leukotrienes in chronic hepatitis. (1988) (0)
- Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21 (2022) (0)
- Long-term prognosis of patients with hepatocellular carcinoma who underwent thermal ablation therapies (2011) (0)
- Significant decrease of mucosal cytoglobin+ pericryptal myofibroblasts in longstanding ulcerative colitis with colorectal neoplasia, correlatively with alpha-SMA and HSP47 phenotypic expression: P-0147. (2009) (0)
- Prevalence of Hepatitis B Surface Antigen Among Apparently Healthy Individuals in Ibadan Nigeria (2018) (0)
- Artificial pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma (2011) (0)
- Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1 (2020) (0)
- Impact of alcohol abstinence on survival after hepatic resection for hepatocellular carcinoma in patients with alcohol-related liver disease (2021) (0)
- Abstract 16720: Cytoglobin Regulates Cardiovascular Function and Vessel Tone by Controlling the Rate of Vascular Nitric Oxide Metabolism (2014) (0)
- T lymphocyte subsets in the peripheral blood in patients with primary biliary cirrhosis. (1989) (0)
- Fascin, an Actin Bundlling Protein, Can Be a Novel Marker of Human Hepatic Stellate Cells and May Regulate Functions of Hscs Through FAK-PI3K-AKT Pathway (2011) (0)
- Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virus (2018) (0)
- Differences between microwave coagulation and radiofrequency ablation for patients with hepatocellular carcinoma who received laparoscopic thermal ablation therapies (2010) (0)
- Real-time PCR assays for hepatitis C virus RNA (genotype 1) is useful for evaluating virological response to the treatment with peginterferon-alpha2b and ribavirin. (2013) (0)
- Antifibrotic agents emerging from traditional herbal medicine (2010) (0)
- A case of hepatocellular carcinoma with "pseudoprogression" followed by complete response to atezolizumab plus bevacizumab. (2023) (0)
- Non-heat-stressed Method to Isolate Hepatic Stellate Cells From Highly Steatotic Tumor-bearing Liver Using CD49a (2022) (0)
- Network of immunological and inflammatory reaction in chronic liver disease. (1989) (0)
- Leukotriene B4 in bile and culture supernatant of kupffer cells in rat (1988) (0)
- Hepatocelluar Carcinoma Risk in Advanced Fibrosis After Sustained Virologic Response: When Can We Safely Stop Hepatocellular Carcinoma Surveillance? (2022) (0)
- EXPRESSION OF GALECTIN-1 AND GALECTIN-3 IN HEPATIC STELLATE CELL AND FIBROTIC LIVER (2001) (0)
- Development of a novel anti-hepatitis B virus agent via Sp1 (2020) (0)
- Molecular and Cellular Aspects of Liver Fibrosis (2005) (0)
- P652 CLINICAL CHARACTERISTICS OF HEPATITIS B VIRUS REACTIVATION IN A PROSPECTIVE LONG-TERM STUDY FOR PATIENTS WITH HEMATOLOGIC MALIGNANCY (2014) (0)
- Efficacy of Polaprezinc in Patients with Hepatitis C Virus−related Liver Cirrhosis (2008) (0)
- TACE for treatment-naive HCC has different treatment effects depending on central or peripheral tumor-location (2023) (0)
- 1168 RESPONSE GUIDED THERAPY BY PEGINTERFERON A2B PLUS RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 2 (2012) (0)
- Alternative methods of radiofrequencty ablation for hepatocellular carcinoma located close to the hepatic dome (2008) (0)
- Validation of a Novel Cutoff Point for the Fibrosis-4 Index Modified by Age in Patients with Fatty Liver Diseases (2021) (0)
- [Drug induced liver injury]. (1995) (0)
- Molecular Analysis of Stellate Cells Activation by Proteomics (2001) (0)
- Analysis of Proteins and Genes Dominantly Expressed in Stellate Cells of Activated Phenotype: the Molecular Approach to Liver Fibrosis (2001) (0)
- Subject Index Vol. 51, Suppl. 1, 2008 (2008) (0)
- [Study on productive activity of leukotrienes in peripheral neutrophils in patients with liver disease]. (1988) (0)
- 98 Unique Expression of Cytoglobin/Stellate Cell Activation-Associated Protein As An Oxygen Supplier Before Angiogenesis During Gastric Ulcer Healing in Rats (2008) (0)
- PROTEOMICS – Clinical Applications Table of Contents (2013) (0)
- Adjuvant epoetin‐β with peginterferon‐α and ribavirin in Japanese ribavirin‐intolerant relapsed patients with chronic hepatitis C genotype 2 (2014) (0)
- Abstracts of selected papers presented at the 30th Annual Meeting of the Japanese Society of Gastroenterology October 20–22, 1988 — Kagoshima, Japan (1991) (0)
- Annual lung cancer screening by chest X ray to avoid further examinations. (2020) (0)
- Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis (2023) (0)
- Per‐rectal portal scintigraphy as an alternative measure of hepatic venous pressure gradient in chronic liver disease: A preliminary report (2021) (0)
- Inside Lab Invest (2012) (0)
- Infection route of hepatitis C patients treated with direct-acting antivirals -To evaluate the risk of reinfection- (2017) (0)
- Selective overexpression of cytoglobin in stellate cells attenuates thioacetamide-induced liver fibrosis in mice (2018) (0)
- Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1 (2020) (0)
- Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination. (2017) (0)
- [Natural history of hepatitis B virus infection]. (2011) (0)
- Crystal Structure of Human Cytoglobin (Ferric Form) (2004) (0)
- Last crusade against HCV: Direct‐acting antiviral treatment for marginalized populations (2019) (0)
- A case of ectopic hepatocellular carcinoma originating from the retroperitoneum (2020) (0)
- Molecular Mechanism and Emerging Therapy of Liver Fibrosis (2018) (0)
- Laparoscopic observation of 2 cases of nodular regenerative hyperplasia of the liver. (2007) (0)
- The regulatory mechanism by extracellular nucleotides in hepatic microcirculation (1995) (0)
- Galectin-1 as a novel mitogen for hepatic stellate cells (2002) (0)
- 131 A STUDY ON A RABBIT MODEL OF STEATOHEPATITIS WITH ADVANCED FIBROSIS (2009) (0)
- Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma (2017) (0)
- Monitoring patients with a resolved hepatitis B virus infection for HBV reactivation (2018) (0)
- Effect of alendronate on bone loss in patients with cirrhosis of the liver (2006) (0)
- Medium-term outcomes of hepatitis C virus-infected patients with a sustained viral response according to albumin-bilirubin grade (2020) (0)
- Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis. (2021) (0)
- Induction of activated T-cell apoptosis by activated hepatic stellate cells in the rat liver (2002) (0)
- Sa128 CYTOGLOBIN IMPAIRS PANCREATIC CANCER GROWTH IN VITRO AND IN VIVO (2021) (0)
- REDOX-REGULATED CELL GROWTH MEDIATED BY CATHEPSIN B-DEPENDENT EXTRACELLULAR PROTEOLYSIS OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR. (2001) (0)
- Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication (2018) (0)
- Is it possible to stop nucleus(t)die analogue safely in patients with preemptive or preventive therapy for HBV reactivation? (2020) (0)
- Platelet activating factor(PAF) and interleukin-1 synthesis by hepatic sinusoidal endothelial cells from mice with carbon tetracholoride liver cell injury. (1990) (0)
- Severity of Liver Fibrosis Is Associated with the Japanese Diet Pattern and Skeletal Muscle Mass in Patients with Nonalcoholic Fatty Liver Disease (2023) (0)
- [Indication of monotherapy with pegylated interferon or interferon for patient with HCV in Japan]. (2011) (0)
- A case of adult-onset Still's disease with macrophage activation syndrome and acute liver failure (2012) (0)
- 971 MICRORNA-29B SUPPRESSES TYPE I COLLAGEN AND SP1 EXPRESSION IN INTERFERON-TREATED STELLATE CELLS (2010) (0)
- Molecular and cellular analysis of stellate cell activation -associated protein (STAP) (2002) (0)
- Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma (2020) (0)
- TNP-470 INHIBITS HEPATIC FIBROSIS OF RATS INDUCED BY CARBON TETRACHLORIDE (CCL_4) AND DIMETHELNITROSAMINE (DMN) (2001) (0)
- 589 The incidence of hepatocellular carcinoma in patients with chronic hepatitis C who achieved sustained virological response to interferon therapy (2006) (0)
- 2P003 Ligand binding mechanism of human Cytoglobin based on X-ray crystal structure (2004) (0)
- CELL CULTURE IN THREE-DIMENSIONAL LATTICES OF HYDRATED COLLAGEN FIBRILS − ITS PROGRESS AND PERSPECTIVES (2015) (0)
- Laparoscopic thermal ablation therapy for hepatocellular carcinoma with forward-viewing laparoscopic ultrasonography (End-Fire array) (2008) (0)
- 133 CYTOGLOBIN-DEFICIENCY PROMOTES THE DEVELOPMENT OF LIVER CANCER IN MOUSE MODELS VIA THE ACTIVATION OF LOCAL FIBROSIS, INFLAMMATION AND OXIDATIVE STRESS (2013) (0)
- Effects of Sho-saiko-to on the Level of Cytosol Esradiol Receptors (1991) (0)
- Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease (2023) (0)
- Indication and results of thermal ablation for hepatocellular carcinoma (2007) (0)
- A mask-based infection control method for screening endoscopy may prevent SARS-CoV-2 transmission and relieve staff anxiety (2021) (0)
- Development of ultrasound-assisted fluorescence imaging of indocyanine green (2016) (0)
- Sulfur-containing amino acids attenuate the stellate cell proliferation and the progress of liver fibrosis in rats (2003) (0)
- Abstract 2894: Intracellular gap formation of the liver sinusoidal endothelial cells facilitates the liver metastasis ability of cancer cells (2021) (0)
- Stimulation of proliferation of hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways (2003) (0)
- 330 Targeted expression of transgenes in hepatic stellate cells using an adenoviral CRE-IoxP system to antagonize hepatic fibrosis (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Norifumi Kawada?
Norifumi Kawada is affiliated with the following schools: